Status:
COMPLETED
Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Anesthesia, General
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Laryngeal mask airway (LMA) is currently the most widely used supraglottic airway device with advantages of simple and fast placement, reduced anesthesia drug use, more stable hemodynamics, and less t...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status I-III
- Age: over 65 years
- Elective orthopedic surgery undergo general anesthesia in supine position
Exclusion
- Anticipated difficult airway (Mallampati score 3-4), limited mouth opening, intra-oral and pharyngeal pathology
- Risk of pulmonary aspiration of gastric contents (full stomach)
- Obesity (Body mass index \> 35)
- Significant lung abnormalities (low lung compliance, high airway resistance, impaired oxygenation)
- Loosening teeth
- Allergic to Cisatracurium or Lidocaine
- Failure in successful LMA insertion after second attempts
Key Trial Info
Start Date :
April 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05310110
Start Date
April 12 2022
End Date
August 24 2023
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Linkup Chang Gung Memorial Hospital
Taoyuan, Taiwan, 33305